A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease

NCT06226545 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Thyroid Eye Disease
Graves Ophthalmopathy
Graves Orbitopathy
Thyroid Associated Ophthalmopathy
Endocrine System Diseases
Orbital Diseases
Proptosis
Eye Diseases

Interventions

DRUG: LASN01
DRUG: LASN01
DRUG: Placebo
DRUG: LASN01

Sponsor

Lassen Therapeutics Inc.